Neogen Chemicals Q2 FY27 consolidated PAT Rs 8.23 cr; revenue Rs 295.96 cr

What the numbers show

• Net margin was 2.78% of revenue, up 116 bps from 1.62%.
• Revenue rose 41.8% while total expenses rose 39.8%.
• Cost of materials took 79.4% of revenue, against 73.3% a year earlier.

Key numbers (consolidated, as per statement of unaudited consolidated financial results)

• Revenue from operations: Rs 295.96 cr (Q2 FY26: Rs 208.66 cr)
• Other income: Rs 3.96 cr (Rs 1.89 cr)
• Total income (net): Rs 299.92 cr (Rs 210.55 cr)
• Cost of materials consumed: Rs 234.88 cr (Rs 152.98 cr)
• Purchase of traded goods: Rs 0.74 cr (Rs –)
• Changes in inventories of finished goods, work-in progress and stock-in-trade: Rs (71.43) cr (Rs (41.43) cr)
• Employee benefits expenses: Rs 30.96 cr (Rs 24.29 cr)
• Finance costs: Rs 27.78 cr (Rs 19.48 cr)
• Depreciation and amortization expenses: Rs 8.79 cr (Rs 7.31 cr)
• Other expenses: Rs 56.23 cr (Rs 42.86 cr)
• Total expenses: Rs 287.21 cr (Rs 205.49 cr)
• Share of profit of associates: Rs 0.01 cr (Rs 0.09 cr)
• Profit/(loss) before exceptional item and taxes: Rs 12.72 cr (Rs 5.15 cr)
• Exceptional items gain/(loss): Rs – (Rs –)
• Profit/(loss) before tax: Rs 12.72 cr (Rs 5.15 cr)
• Current tax: Rs 6.29 cr (Rs 3.76 cr)
• Deferred tax: Rs (1.80) cr (Rs (1.90) cr)
• Prior year tax adjustment: Rs – (Rs (0.08) cr)
• Profit for the period (PAT): Rs 8.23 cr (Rs 3.37 cr)
• Total other comprehensive (expense)/income, net of tax: Rs (0.94) cr (Rs (0.11) cr)
• Total comprehensive income for the period: Rs 7.29 cr (Rs 3.26 cr)
• Paid up equity share capital: Rs 30.02 cr (Rs 26.38 cr)
• Earnings per equity share (Basic & Diluted, not annualised): Rs 2.96* (Rs 1.28*)

For the half year ended September 30, 2026, consolidated revenue from operations was Rs 546.25 cr, compared with Rs 395.38 cr for the half year ended September 30, 2025, as shown in the statement of unaudited consolidated financial results. Total income (net) for the half year stood at Rs 554.07 cr versus Rs 398.45 cr a year earlier.

Total expenses for the half year were Rs 518.28 cr, up from Rs 379.14 cr in the corresponding half year. Within this, cost of materials consumed was Rs 414.90 cr (Rs 281.35 cr), employee benefits expenses were Rs 56.26 cr (Rs 43.86 cr), finance costs were Rs 48.60 cr (Rs 32.14 cr), depreciation and amortization expenses were Rs 16.99 cr (Rs 13.09 cr), and other expenses were Rs 99.22 cr (Rs 76.76 cr). Changes in inventories of finished goods, work-in progress and stock-in-trade were reported at Rs (118.43) cr for the half year, compared with Rs (68.06) cr in the prior half year.

Share of profit of associates for the half year was Rs 0.21 cr, versus Rs 0.14 cr in the corresponding period. Profit/(loss) before exceptional item and taxes for the half year was Rs 36.00 cr, compared with Rs 19.45 cr a year earlier. There were no exceptional items reported in either period in the consolidated statement of financial results.

Profit for the half year (PAT) was Rs 25.34 cr, against Rs 13.65 cr in the half year ended September 30, 2025. Earnings per equity share (Basic & Diluted, not annualised) for the half year were Rs 9.21*, compared with Rs 5.18* in the corresponding half year, as per the same table.